comprehensive -WSS

comprehensive

author：fashion 2025-10-02 21:05:01 - browse：9

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： What the Wegovy shortage looks like for doctors — and for patients

WSS

Wellcome Trust names Røttingen as its new CEO

Readout LOUD: Venture capital, Gilead, and more M&A

340B reform proposal comes out of Senate working group

Readout LOUD: Venture capital, Gilead, and more M&A

Nick Jonas talks about managing diabetes along with his career

What’s missing from the debate over nursing home staff minimums

hotspot

comprehensive

knowledge

Jerome Adams on the need for new antivirals for Covid

Unique patient identifier: Experts argue the benefits, pitfalls

At least 13 dead in Texas as scorching temps continue

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Anesthesiologist group: stop taking Ozempic before surgery

Massive project maps cells in human brain in unprecedented detail

Alkermes shareholders re

Female surgeons have lower rates of long

explore

Updated Covid vaccine has 54% effectiveness, new study suggests

A revolution in caring for preterm infants

Eight reasons why you should get an updated Covid vaccine

Takeaways from AdvaMed, the largest medical devices conference

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

STAT Readout: Today's biotech news includes Sana and Amylyx

knowledge

hotspot

Wikipedia

focus